标题
PCSK9: A Potential Therapeutic Target for Sepsis
作者
关键词
-
出版物
Journal of Immunology Research
Volume 2020, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2020-10-16
DOI
10.1155/2020/2687692
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inclisiran: UK to roll out new cholesterol lowering drug from next year
- (2020) Gareth Iacobucci BMJ-British Medical Journal
- PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study
- (2020) A. Vecchié et al. JOURNAL OF INTERNAL MEDICINE
- Emerging role of proprotein convertase subtilisin/kexin type-9 (PCSK-9) in inflammation and diseases
- (2019) Madalyn Brown et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Reduced Proprotein convertase subtilisin/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients
- (2019) Alex K. K. Leung et al. Scientific Reports
- PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
- (2019) Ji Soo Lee et al. Scientific Reports
- Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units
- (2019) Tannaz Jamialahmadi et al. Journal of Clinical Medicine
- Very Low Density Lipoprotein Receptor Sequesters Lipopolysaccharide Into Adipose Tissue During Sepsis
- (2019) Tadanaga Shimada et al. CRITICAL CARE MEDICINE
- PCSK9 induces a pro-inflammatory response in macrophages
- (2018) Chiara Ricci et al. Scientific Reports
- Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients
- (2018) Qi Xia et al. MEDIATORS OF INFLAMMATION
- Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors
- (2018) Kelly Roveran Genga et al. EBioMedicine
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice
- (2017) Jean-Mathieu Berger et al. JOURNAL OF LIPID RESEARCH
- The obesity conundrum in sepsis
- (2017) Pauline Yeung Ng et al. BMC Anesthesiology
- Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study
- (2017) Massimiliano Ruscica et al. Journal of the American Heart Association
- PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
- (2016) Jin M. Cheng et al. ATHEROSCLEROSIS
- Shedding light on FGF21: A potential negative regulator of PCSK9
- (2016) Yuan Guo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A review of PCSK9 inhibition and its effects beyond LDL receptors
- (2016) Dave L. Dixon et al. Journal of Clinical Lipidology
- Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis
- (2016) John H. Boyd et al. Journal of Innate Immunity
- Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis
- (2016) Dhruva J. Dwivedi et al. SHOCK
- Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
- (2015) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a)
- (2015) Keith C. Ferdinand et al. CARDIOVASCULAR DRUGS AND THERAPY
- Understanding PCSK9 and anti-PCSK9 therapies
- (2015) James M. McKenney Journal of Clinical Lipidology
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- PCSK9 is a critical regulator of the innate immune response and septic shock outcome
- (2014) K. R. Walley et al. Science Translational Medicine
- Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
- (2013) Kevin Fitzgerald et al. LANCET
- PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
- (2012) ZHIHAN TANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Celastrol attenuates adipokine resistin-associated matrix interaction and migration of vascular smooth muscle cells
- (2012) Sang-Wook Kang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Plasma PLTP (phospholipid-transfer protein): an emerging role in ‘reverse lipopolysaccharide transport’ and innate immunity
- (2011) Thomas Gautier et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Macrophages in the Pathogenesis of Atherosclerosis
- (2011) Kathryn J. Moore et al. CELL
- Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling
- (2011) M. B. Fessler et al. JOURNAL OF IMMUNOLOGY
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cells
- (2010) Hong Lan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
- (2010) Bin Dong et al. JOURNAL OF LIPID RESEARCH
- Resistin competes with lipopolysaccharide for binding to toll-like receptor 4
- (2009) Andrej Tarkowski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
- (2009) Cameron R Stewart et al. NATURE IMMUNOLOGY
- Inflammation stimulates the expression of PCSK9
- (2008) Kenneth R. Feingold et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
- (2008) Janice Mayne et al. Lipids in Health and Disease
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search